Related Experiment Video
Updated: Jul 27, 2026

06:16
Rat Heterotopic Abdominal Heart/Single-lung Transplantation in a Volume-loaded Configuration
Published on: May 29, 2015
Controlled non-heart-beating donor liver transplantation: a successful single center experience, with topic update
D J Reich1, S J Munoz, K D Rothstein
1Department of Surgery, Albert Einstein Medical Center, Philadelphia, Pennsylvania 19141, USA. reichd@aehn2.einstein.edu
Transplantation
|November 4, 2000
Summary
Controlled non-heart-beating donor (NHBD) liver transplantation offers a safe and effective method to expand the organ donor pool. This approach achieved excellent patient and graft survival rates, demonstrating its viability.
Area of Science:
- Transplantation immunology
- Organ procurement strategies
- Surgical innovation
Background:
- Critical shortage of transplantable organs necessitates exploring unconventional donor sources.
- Successful implementation of controlled non-heart-beating donor (NHBD) liver transplantation is reported.
Purpose of the Study:
- To evaluate the feasibility and outcomes of liver transplantation using organs from controlled non-heart-beating donors.
- To assess the safety and efficacy of NHBD liver transplantation in expanding the donor pool.
Main Methods:
- Organs were recovered from controlled NHBDs following withdrawal of life support and death determination.
- Rapid aortic cannulation and organ procurement were performed after cessation of ventilation.
- Liver and kidney recovery procedures were standardized for NHBDs.
Main Results:
- Controlled NHBDs provided 5% of hepatic allografts during the study period.
- All patients (n=8) and grafts achieved 100% survival at 18 months post-transplant.
- No major complications such as primary nonfunction, thrombosis, or serious infection were observed.
Conclusions:
- NHBDs significantly and safely expand the organ donor pool for liver transplantation.
- Rapid procurement by skilled surgical teams is crucial for successful NHBD liver transplantation.
- Liberalizing acceptance criteria for NHBD livers, with refined ethics, is warranted.

